Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 14:2:52.
doi: 10.3410/M2-52.

Recent advances in pharmacological treatment of neuropathic pain

Recent advances in pharmacological treatment of neuropathic pain

Nanna Brix Finnerup et al. F1000 Med Rep. .

Abstract

Recent studies investigating the pharmacological management of neuropathic pain support the efficacy of certain antidepressants, anticonvulsants, and opioids. Novel directions in drug applications include topical applications of patches with either lidocaine or capsaicin and intradermal injections of botulinum toxin. In cases of partial pain relief, drug combinations may be considered.

PubMed Disclaimer

References

    1. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5. doi: 10.1212/01.wnl.0000282763.29778.59. - DOI - PubMed
    1. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289–305. - PubMed
    2. <ext-link ext-link-type="uri" xlink:href="http://www.f1000medicine.com/article/id/10333">F1000 Factor 6.0 Must Read</ext-link>

      Evaluated by Michael Serpell 14 Mar 2006

    1. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain. 2007;132:237–51. - PubMed
    2. <ext-link ext-link-type="uri" xlink:href="http://www.f1000medicine.com/article/id/1116530">F1000 Factor 6.0 Must Read</ext-link>

      Evaluated by Andreas Kopf 16 Jul 2008

    1. Gordh TE, Stubhaug A, Jensen TS, Arner S, Biber B, Boivie J, Mannheimer C, Kalliomaki J, Kalso E. Gabapentin in traumatic nerve injury pain: A randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain. 2008;138:255–66. - PubMed
    2. <ext-link ext-link-type="uri" xlink:href="http://www.f1000medicine.com/article/id/1141888">F1000 Factor 3.0 Recommended</ext-link>

      Evaluated by Claudia Sommer 09 Jan 2009

    1. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain. 2008;9:1006–17. doi: 10.1016/j.jpain.2008.05.014. - DOI - PubMed
    2. <ext-link ext-link-type="uri" xlink:href="http://www.f1000medicine.com/article/id/1158082">F1000 Factor 3.0 Recommended</ext-link>

      Evaluated by Kenneth Candido 12 Mar 2009